S. Ak Aksoy Et Al. , "Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis," MOLECULAR BIOLOGY REPORTS , vol.49, no.12, pp.11243-11253, 2022
Ak Aksoy, S. Et Al. 2022. Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis. MOLECULAR BIOLOGY REPORTS , vol.49, no.12 , 11243-11253.
Ak Aksoy, S., Tunca, B., Erçelik, M., Tezcan, G., Ozturk, E., Cecener, G., ... Ugras, N.(2022). Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis. MOLECULAR BIOLOGY REPORTS , vol.49, no.12, 11243-11253.
Ak Aksoy, SEÇİL Et Al. "Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis," MOLECULAR BIOLOGY REPORTS , vol.49, no.12, 11243-11253, 2022
Ak Aksoy, SEÇİL Et Al. "Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis." MOLECULAR BIOLOGY REPORTS , vol.49, no.12, pp.11243-11253, 2022
Ak Aksoy, S. Et Al. (2022) . "Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis." MOLECULAR BIOLOGY REPORTS , vol.49, no.12, pp.11243-11253.
@article{article, author={SEÇİL AKSOY Et Al. }, title={Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis}, journal={MOLECULAR BIOLOGY REPORTS}, year=2022, pages={11243-11253} }